17.40
-1.60
(-8.42%)
At close: March 3 at 4:00:02 PM EST
17.00
-0.40
(-2.30%)
After hours: March 3 at 6:19:17 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | -1.87 | -2.15 | -7.8 | -4.27 |
| Low Estimate | -2.03 | -2.15 | -8.02 | -5.76 |
| High Estimate | -1.7 | -2.15 | -7.57 | -2.78 |
| Year Ago EPS | -1.88 | -1.5 | -8.23 | -7.8 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.35 | -1.35 | -1.8 | -1.8 |
| EPS Actual | -1.88 | -1.5 | -2.25 | -2.18 |
| Difference | -0.52 | -0.15 | -0.45 | -0.38 |
| Surprise % | -38.89% | -11.11% | -25.00% | -21.11% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.87 | -2.15 | -7.8 | -4.27 |
| 7 Days Ago | -1.95 | -1.5 | -7.43 | -5.62 |
| 30 Days Ago | -1.95 | -1.5 | -7.43 | -5.62 |
| 60 Days Ago | -1.95 | -1.5 | -7.43 | -5.62 |
| 90 Days Ago | -1.95 | -1.5 | -7.43 | -5.62 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | 1 | -- | 1 | -- |
| Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVKD | 0.53% | -43.33% | 5.26% | 45.22% |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/9/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/14/2024 |
| Initiated | Noble Capital Markets: Outperform | 12/18/2023 |
| Initiated | HC Wainwright & Co.: Buy | 11/20/2023 |
Related Tickers
ICU SeaStar Medical Holding Corporation
1.7700
+2.31%
STRO Sutro Biopharma, Inc.
1.4350
-9.75%
ZVSA ZyVersa Therapeutics, Inc.
1.0500
-7.08%
STTK Shattuck Labs, Inc.
1.2200
-7.58%
MAIA MAIA Biotechnology, Inc.
1.7000
-9.57%
IKT Inhibikase Therapeutics, Inc.
2.2700
-1.30%
SCPH scPharmaceuticals Inc.
3.2100
-2.13%
ACRV Acrivon Therapeutics, Inc.
5.14
-3.20%
CGON CG Oncology, Inc.
25.10
-2.94%
PTIX Protagenic Therapeutics, Inc.
0.2763
-9.41%